Guardant Health Inc (GH)
Guardant Health, Inc. - Guardant Health Receives FDA Approval forGuardant360® CDx as a Companion Diagnostic for Arvinas andPfizer’s VEPPANU (vepdegestrant) for Patients with ER+/HER2- Advanced Breast Cancer with ESR1 Mutations
GUARDANT HEALTH, INC. (GH)
Guardant Health Receives FDA Approval for Guardant360® CDx as a Companion Diagnostic for Arvinas and Pfizer’s VEPPANU (vepdegestrant) for Patients with ER+/HER2- Advanced Breast Cancer with ESR1 Mutations
CITIGROUP INC (C)
ALTO NEUROSCIENCE, INC. (ANRO)
Alto Neuroscience Presents Phase 2a Data for ALTO-207 in Major Depressive Disorder at SOBP Annual Meeting
TORONTO DOMINION BANK (TD)
Johnson & Johnson (JNJ)
Johnson & Johnson - CAPLYTA® (lumateperone) showed greatest improvement across key efficacy outcomes among adjunctive MDD treatments in new network meta-analysis
Edgewise Therapeutics Inc (EWTX)
Edgewise Therapeutics - Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
Assertio Holdings Inc. (ASRT)
Assertio Holdings, Inc. - Assertio Announces Amended and Restated Merger Agreement with Garda Therapeutics
XENCOR INC (XNCR)
Xencor to Host Webcast to Discuss XmAb942 and XmAb412 Data Presentations at DDW
ADDUS HOMECARE CORP (ADUS)
Mirum Pharmaceuticals Inc (MIRM)
Mirum Pharma - Mirum Pharmaceuticals Announces Primary Endpoint Met in VISTAS Study of Volixibat in Patients with Primary Sclerosing Cholangitis
KEPPEL LTD. (BN4)
Agilent Technologies Inc. (A)
Agilent Technologies, Inc. - Agilent Names Michael Buckner as Chief Legal Officer